Sun | Sep 20, 2020

Global coronavirus cases top 20M as Russia approves vaccine

Published:Tuesday | August 11, 2020 | 9:13 AM
In this file photo made from footage provided by the Russian Defense Ministry on Wednesday, July 15, 2020, medical workers in protective gear prepare to draw blood from volunteers participating in a trial of a coronavirus vaccine at the Budenko Main Military Hospital outside Moscow, Russia. (Russian Defense Ministry Press Service via AP, File)

ROME (AP) — The number of confirmed coronavirus cases worldwide topped 20 million, more than half of them from the United States, India and Brazil, as Russia on Tuesday became the first country to approve a vaccine against the virus.

Russian President Vladimir Putin said that one of his two adult daughters had already been inoculated with the cleared vaccine, which he described as effective. “She’s feeling well and has a high number of antibodies,” Putin said.

Russia has reported more than 890,000 cases, the fourth-highest total in the world, according to a Johns Hopkins University tally that also showed total confirmed cases globally surpassing 20 million.

It took six months or so to get to 10 million cases after the virus first appeared in central China late last year. It took just over six weeks for that number to double.

An AP analysis of data through August 9 showed the US, India and Brazil together accounted for nearly two-thirds of all reported infections since the world hit 15 million coronavirus cases on July 22.

Health officials believe the actual number of people infected with the virus is much higher than the tally kept by Johns Hopkins University, given testing limitations and that as many as 40% of those with the virus show no symptoms.

As a result, the race to develop and deliver a vaccine has topped the global health care and geopolitical agenda, even as the United Nations has warned that any vaccine must be safe and made available to all, not just the wealthy.

Putin said the Russian vaccine underwent the necessary tests and offered a lasting immunity from the coronavirus. But scientists at home and abroad have warned that rushing to start using the vaccine before Phase 3 trials — which normally last for months and involve thousands of people — could backfire.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us @onlinefeedback@gleanerjm.com or editors@gleanerjm.com.